Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-02-29
1986-02-04
Rollins, Alton D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 94, 548262, 548473, A61K 3141, C07D24908, C07D40306
Patent
active
045686858
ABSTRACT:
N-[(1H-1,2,4-Triazol-l-yl)alkyl]arylamides which are inhibitors of thromboxane synthetase enzyme.
REFERENCES:
patent: 4320134 (1982-03-01), Iizuka et al.
Burger, Medicinal Chemistry, (Second Ed., New York, 1960), pp. 79-81.
Press Jeffery B.
Tomcufcik Andrew S.
Wright, Jr. William B.
American Cyanamid Company
Rollins Alton D.
Timbers M.-E. M.
LandOfFree
N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2341154